BTMD
Price:
$4.04
Market Cap:
$154.71M
biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women. The company was founded in 2011 and is headquartered in Irvine, Texas.
Industry
Medical - Care Facilities
IPO Date
2021-04-28
Stock Exchange
NASDAQ
Ticker
BTMD
According to biote Corp.’s latest financial reports and current stock price. The company's current ROE is -18.92%. This represents a change of 219.38% compared to the average of -5.92% of the last 4 quarters.
The mean historical ROE of biote Corp. over the last ten years is 89.68%. The current -18.92% ROE has changed -121.10% with respect to the historical average. Over the past ten years (40 quarters), BTMD's ROE was at its highest in in the June 2021 quarter at 195.22%. The ROE was at its lowest in in the September 2021 quarter at -630.97%.
Average
89.68%
Median
-7.13%
Minimum
-170.79%
Maximum
790.76%
Discovering the peaks and valleys of biote Corp. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 278.78%
Maximum Annual ROE = 790.76%
Minimum Annual Increase = -563.01%
Minimum Annual ROE = -170.79%
Year | ROE | Change |
---|---|---|
2024 | -2.98% | -73.58% |
2023 | -11.28% | 278.78% |
2022 | -2.98% | -100.38% |
2021 | 790.76% | -563.01% |
2020 | -170.79% | 164.18% |
The current ROE of biote Corp. (BTMD) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-5.75%
5-year avg
120.55%
10-year avg
89.68%
biote Corp.’s ROE is less than Addus HomeCare Corporation (8.24%), less than BioCorRx Inc. (40.30%), less than Comera Life Sciences Holdings, Inc. (172.01%), greater than Alpha Tau Medical Ltd. (-49.48%), greater than Enhabit, Inc. (-31.16%), greater than Grove Collaborative Holdings, Inc. (-166.15%),
Company | ROE | Market cap |
---|---|---|
8.24% | $2.06B | |
40.30% | $6.46M | |
172.01% | $6.15K | |
-49.48% | $273.58M | |
-31.16% | $358.51M | |
-166.15% | $59.98M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like biote Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like biote Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is biote Corp.'s ROE?
How is the ROE calculated for biote Corp. (BTMD)?
What is the highest ROE for biote Corp. (BTMD)?
What is the 3-year average ROE for biote Corp. (BTMD)?
What is the 5-year average ROE for biote Corp. (BTMD)?
How does the current ROE for biote Corp. (BTMD) compare to its historical average?